Michael Costa - Amer Renal Vice President General Counsel, Secretary

President

Mr. Michael R. Costa, Esq. is Vice President, General Counsel, Secretary of the Company. Mr. Costa has served as our Vice President and General Counsel since 2007. Mr. Costa has more than 18 years experience as a corporate healthcare attorney. Prior to joining our company, from 2001 to 2005, Mr. Costa served as an Associate and, from 2006 to 2007, as Senior Counsel in the Health Business Group of Greenberg Traurig LLP. From 1999 to 2001, Mr. Costa served as an attorney at Behar Kalman LLP in Boston, Massachusetts
Age 46
Phone978 922-3080
Webwww.americanrenal.com
Costa holds a B.S. degree in Legal Studies and Business Management from Roger Williams University, an M.P.H. from Boston University School of Public Health and a J.D. from Suffolk University Law School.

Michael Costa Latest Insider Activity

Tracking and analyzing the buying and selling activities of Michael Costa against Amer Renal stock is an integral part of due diligence when investing in Amer Renal. Michael Costa insider activity provides valuable insight into whether Amer Renal is net buyers or sellers over its current business cycle. Note, Amer Renal insiders must abide by specific rules, including filing SEC forms every time they buy or sell Amer Renal'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Amer Renal Management Efficiency

The company has Return on Asset of 4.35 % which means that on every $100 spent on assets, it made $4.35 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 17.51 %, implying that it generated $17.51 on every 100 dollars invested. Amer Renal's management efficiency ratios could be used to measure how well Amer Renal manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 724.51 M in debt with debt to equity (D/E) ratio of 3.94, meaning that the company heavily relies on borrowing funds for operations. Amer Renal Assoc has a current ratio of 1.03, demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due. Debt can assist Amer Renal until it has trouble settling it off, either with new capital or with free cash flow. So, Amer Renal's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amer Renal Assoc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amer to invest in growth at high rates of return. When we think about Amer Renal's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Darren RebelezDine Brands Global
52
Jay JohnsDine Brands Global
63
Brian CarmichallEl Pollo Loco
60
Greggory KalvinDine Brands Global
57
David GordonThe Cheesecake Factory
59
Tony MoralejoDine Brands Global
59
Anthony CPAArk Restaurants Corp
60
Cheryl SlomannThe Cheesecake Factory
58
Max ByfuglinThe Cheesecake Factory
70
Allison HallDine Brands Global
59
Darryl MarschWingstop
51
Matthew ClarkThe Cheesecake Factory
54
Larry KrugerWingstop
51
Jill PetersThe Cheesecake Factory
N/A
Scarlett MayThe Cheesecake Factory
58
Daniel OlmoDine Brands Global
41
John CywinskiDine Brands Global
61
Lawrence KruguerWingstop
52
Gustavo SiadeEl Pollo Loco
55
Robert StewartArk Restaurants Corp
58
Bryan AdelDine Brands Global
57
American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. The company was founded in 1999 and is headquartered in Beverly, Massachusetts. American Renal operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 4977 people. Amer Renal Assoc (ARA) is traded on New York Stock Exchange in USA and employs 4,977 people.

Management Performance

Amer Renal Assoc Leadership Team

Elected by the shareholders, the Amer Renal's board of directors comprises two types of representatives: Amer Renal inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amer. The board's role is to monitor Amer Renal's management team and ensure that shareholders' interests are well served. Amer Renal's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amer Renal's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jason Boucher, Chief Accounting Officer, Vice President - Finance, Treasurer
Steven Silver, Independent Director
Patrick Ryan, Independent Director
Thomas Erickson, Independent Director
John Jureller, Independent Director
Jonathan Wilcox, CFO, Vice President
Michael Costa, Vice President General Counsel, Secretary
Robert Fish, Independent Director
Joseph Carlucci, Chairman of the Board, Chief Executive Officer, Co-Founder
Jeremy Gelber, Independent Director
Don Williamson, Chief Operating Officer, Executive Vice President
Christopher Hocevar, Independent Director
Syed Kamal, President, Co-Founder, Director
Jared Hendricks, Independent Director
John McDonough, COO, Executive Vice President Treasurer
Michael Boxer, Independent Director
Susanne Clark, Independent Director
Mark Herbers, Interim Chief Financial Officer, Interim Chief Accounting Officer

Amer Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amer Renal a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amer Renal in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amer Renal's short interest history, or implied volatility extrapolated from Amer Renal options trading.

Pair Trading with Amer Renal

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amer Renal position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amer Renal will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Consideration for investing in Amer Stock

If you are still planning to invest in Amer Renal Assoc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Renal's history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.